158 related articles for article (PubMed ID: 22180430)
1. Expression of the c-Met oncogene by tumor cells predicts a favorable outcome in classical Hodgkin's lymphoma.
Xu C; Plattel W; van den Berg A; Rüther N; Huang X; Wang M; de Jong D; Vos H; van Imhoff G; Viardot A; Möller P; Poppema S; Diepstra A; Visser L
Haematologica; 2012 Apr; 97(4):572-8. PubMed ID: 22180430
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-1 receptor is associated with better prognosis in classical Hodgkin's lymphoma: Correlation with MET expression.
Koh YW; Yoon DH; Suh C; Cha HJ; Huh J
Int J Exp Pathol; 2015 Aug; 96(4):232-9. PubMed ID: 25916750
[TBL] [Abstract][Full Text] [Related]
3. LGALS3 as a prognostic factor for classical Hodgkin's lymphoma.
Koh YW; Jung SJ; Park CS; Yoon DH; Suh C; Huh J
Mod Pathol; 2014 Oct; 27(10):1338-44. PubMed ID: 24603587
[TBL] [Abstract][Full Text] [Related]
4. MET and MST1R as prognostic factors for classical Hodgkin's lymphoma.
Wha Koh Y; Park C; Hyun Yoon D; Suh C; Huh J
Mod Pathol; 2013 Sep; 26(9):1172-82. PubMed ID: 23558571
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
[TBL] [Abstract][Full Text] [Related]
7. Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease.
Teofili L; Di Febo AL; Pierconti F; Maggiano N; Bendandi M; Rutella S; Cingolani A; Di Renzo N; Musto P; Pileri S; Leone G; Larocca LM
Blood; 2001 Feb; 97(4):1063-9. PubMed ID: 11159538
[TBL] [Abstract][Full Text] [Related]
8. The Met/hepatocyte growth factor receptor (HGFR) gene is overexpressed in some cases of human leukemia and lymphoma.
Jücker M; Günther A; Gradl G; Fonatsch C; Krueger G; Diehl V; Tesch H
Leuk Res; 1994 Jan; 18(1):7-16. PubMed ID: 8289471
[TBL] [Abstract][Full Text] [Related]
9. Functional and therapeutic relevance of hepatocyte growth factor/c-MET signaling in synovial sarcoma.
Imura Y; Nakai T; Yamada S; Outani H; Takenaka S; Hamada K; Araki N; Itoh K; Yoshikawa H; Naka N
Cancer Sci; 2016 Dec; 107(12):1867-1876. PubMed ID: 27779808
[TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma.
Kamper P; Bendix K; Hamilton-Dutoit S; Honoré B; Nyengaard JR; d'Amore F
Haematologica; 2011 Feb; 96(2):269-76. PubMed ID: 21071500
[TBL] [Abstract][Full Text] [Related]
11. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.
Steidl C; Lee T; Shah SP; Farinha P; Han G; Nayar T; Delaney A; Jones SJ; Iqbal J; Weisenburger DD; Bast MA; Rosenwald A; Muller-Hermelink HK; Rimsza LM; Campo E; Delabie J; Braziel RM; Cook JR; Tubbs RR; Jaffe ES; Lenz G; Connors JM; Staudt LM; Chan WC; Gascoyne RD
N Engl J Med; 2010 Mar; 362(10):875-85. PubMed ID: 20220182
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma.
Porrata LF; Ristow K; Colgan JP; Habermann TM; Witzig TE; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Nowakowski GS; Thompson C; Markovic SN
Haematologica; 2012 Feb; 97(2):262-9. PubMed ID: 21993683
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical prognostic factors of primary refractory Hodgkin's lymphoma].
Filatova LV; Gershanovich ML; Plotnikova AA; Turkevich EA; Ivantsov AO; Klimashevskiĭ VF
Vopr Onkol; 2014; 60(5):625-9. PubMed ID: 25816669
[TBL] [Abstract][Full Text] [Related]
15. Frequent hepatocyte growth factor overexpression and low frequency of c-Met gene amplification in human papillomavirus-negative tonsillar squamous cell carcinoma and their prognostic significances.
Kwon MJ; Kim DH; Park HR; Shin HS; Kwon JH; Lee DJ; Kim JH; Cho SJ; Nam ES
Hum Pathol; 2014 Jul; 45(7):1327-38. PubMed ID: 24810547
[TBL] [Abstract][Full Text] [Related]
16. Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma.
Gotti M; Nicola M; Lucioni M; Fiaccadori V; Ferretti V; Sciarra R; Costanza M; Bono E; Molo S; Maffi A; Croci GA; Varettoni M; Frigeni M; Pascutto C; Arcaini L; Bonfichi M; Paulli M; Cazzola M
Hematol Oncol; 2017 Sep; 35(3):296-302. PubMed ID: 27060262
[TBL] [Abstract][Full Text] [Related]
17. c-Met in esophageal squamous cell carcinoma: an independent prognostic factor and potential therapeutic target.
Ozawa Y; Nakamura Y; Fujishima F; Felizola SJ; Takeda K; Okamoto H; Ito K; Ishida H; Konno T; Kamei T; Miyata G; Ohuchi N; Sasano H
BMC Cancer; 2015 Jun; 15():451. PubMed ID: 26036285
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and prognostic factors in Chinese patients with Hodgkin's lymphoma.
Zhu YJ; Sun YL; Xia Y; Jiang WQ; Huang JJ; Huang HQ; Lin TY; Guan ZZ; Li ZM
Med Oncol; 2012 Jun; 29(2):1127-33. PubMed ID: 21390515
[TBL] [Abstract][Full Text] [Related]
19. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
[TBL] [Abstract][Full Text] [Related]
20. Expression of hepatocyte growth factor and its receptor c-met in human leukemia-lymphoma cell lines.
Pons E; Uphoff CC; Drexler HG
Leuk Res; 1998 Sep; 22(9):797-804. PubMed ID: 9716011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
